Absorption, distribution, metabolism, and excretion of dirlotapide in the dog

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue SUPPL. 1, 2007, Pages 17-23

  Merritt, D A ^a   Bessire, A J ^a   Vaz, A D ^a   Sams, J P ^a   Lynch, M P ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; DIRLOTAPIDE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; BRAIN; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; ENTEROHEPATIC CIRCULATION; FECES; FEMALE; GALLBLADDER; GASTROINTESTINAL TRACT; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SINGLE DRUG DOSE; TANDEM MASS SPECTROMETRY;

ADMINISTRATION, ORAL; ANIMALS; ANTI-OBESITY AGENTS; BILE; CARBAMATES; CARBON RADIOISOTOPES; DOGS; FEMALE; INDOLES; MALE; TISSUE DISTRIBUTION;

CANIS FAMILIARIS;

EID: 34249787576     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00865.x     Document Type: Article

References (7)

1. Chandler, C.E., Wilder, D.E., Pettini, J.L., Savoy, Y.E., Petras, S.F., Chang, G., Vincent, J. Harwood, H.J. (2003) CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. Journal of Lipid Research, 44, 1887 1901.
2. Hamilton, R.A., Garnett, W.R. Kline, B.J. (1981) Determination of mean valproic acid serum level by assay of a single pooled sample. Clinical Pharmacology and Therapeutics, 29, 408 413.
3. Merritt, D.A., Lynch, M.P. King, V.L. (2007) Pharmacokinetics of dirlotapide in the dog. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 24 32.
4. Wetterau, J.R., Lin, M.C.M. Jamil, H. (1997) Review: microsomal triglyceride transfer protein. Biochimica et Biophysica Acta, 1345, 136 150.
5. Williams, S. Best, J. (2003) Novel microsomal triglyceride transfer protein inhibitors. Expert Opinion on Therapeutic Patents, 13, 479 488.
6. Wren, J.A., Gossellin, J. Sunderland, S.J. (2007a) Dirlotapide: a review of its properties and role in the management of obesity in dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 11 16.
7. Wren, J.A., King, V.L., Campbell, S.L. Hickman, M.A. (2007b) Biologic activity of dirlotapide, a novel microsomal triglyceride transfer protein inhibitor, for weight loss in obese dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 33 42.